
Find out more about the start-ups mentored
MicroOmix
MicroOmiX develops a “single cell” analysis technology based on droplet microfluidics and an ultrasensitive proprietary system to detect secreted molecules.
Learn more...HifiBio Therapeutics
Launched in 2014 by Medalis, HiFiBiO Therapeutics develops new therapeutic antibodies to combat cancer, auto-immune and infectious diseases.
Learn more...Inoviem scientific
Inoviem Scientific was the first company mentored by Medalis in 2011, it performs innovative pre-clinical analyses to accelerate the development of new drugs and facilitate the emergence of personalised medicine.
Learn more...Syndivia
Syndivia develops new anti-cancer treatments by exploiting the unique properties of cancerous cells and their microenvironment.
Learn more...Peptimimesis
PeptiMimesis is a strategic partner in the design, discovery and early development of therapeutic transmembrane peptides.
Learn more...Adaptherapy
ADAPTHERAPY® develops solutions aiming to help clinicians to select the most appropriate therapy for each patient with cancer or other complex diseases.
Learn more...Biodol
Biodol develops a therapeutic solution to treat neuropathic pain, a chronic disease that affects 7 to 10% of the population in France.
Learn more...MicroOmix
MicroOmiX develops a “single cell” analysis technology based on droplet microfluidics and an ultrasensitive proprietary system to detect secreted molecules.
Learn more...HifiBio Therapeutics
Launched in 2014 by Medalis, HiFiBiO Therapeutics develops new therapeutic antibodies to combat cancer, auto-immune and infectious diseases.
Learn more...